| Application no. and date | 13748243.6 (espacenet) (Federated) (European Patent Register), 20130805 | | Patent/reg. no. and date | DK/EP 2882440, 20190227 | | Publication date | 20150617 | | Priority no. and date | US 201261680473 P, 20120807 | | EP pub. no. and date |
EP 2882440 20150617 | | Effective date | | | Applicant/owner | Array Biopharma, Inc., 3200 Walnut Street
Boulder, CO 80301
, US | | Applicant ref. no. | D. Young & Co. LLP P107281EPZCW | | Inventor | MOUTOUH-DE PARSEVAL, Laure, c/o Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
CAPONIGRO, Giordano, c/o Novartis Institutes for
BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge
Massachusetts 02139, US,
STUART, Darrin, c/o Novartis Vaccines and Diagnostics Inc.
4560 Horton Street
Emeryville
California 94608, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 31/506 (2006.01) , A61K 31/517 (2006.01) , A61P 35/00 (2006.01) | | Title | FARMACEUTISKE KOMBINATIONER, DER OMFATTER EN B-RAF-INHIBITOR, EN EGFR-INHIBITOR OG EVENTUELT EN PI3K-ALFA-INHIBITOR | | Int. application no. | US2013053619 | | Int. publication no. | WO2014025688 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
